NCT06152536 (VEG-EAT) is a NA clinical trial of Vegetarian Meal in Type2diabetes, sponsored by IRCCS San Raffaele.

Who is sponsoring NCT06152536?

NCT06152536 is sponsored by IRCCS San Raffaele.

What drugs are being tested in NCT06152536?

Interventions in NCT06152536: Vegetarian Meal.

What condition does NCT06152536 study?

NCT06152536 studies Type2diabetes, Obesity, Diet, Healthy, Nutrition, Healthy.

Is NCT06152536 still recruiting?

NCT06152536 is currently status unknown. Last updated 30 November 2023.

Last reviewed 2023-11-30 · How we verify

NCT06152536: VEG-EAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of a Vegetarian Meal on the Physiology of Insulin Response in Patients With Type 2 Diabetes Mellitus and Obesity

Status unknown NA Last updated 30 November 2023

What this trial tests

NA trial testing Vegetarian Meal in Type2diabetes in 20 participants. Status unknown.

Timeline

9 June 2022

Primary endpoint
30 September 2024

30 September 2024

Quick facts

Lead sponsor	IRCCS San Raffaele
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	20
Start date	9 June 2022
Primary completion	30 September 2024
Estimated completion	30 September 2024
Sites	1 location across Italy

Drugs / interventions tested

Vegetarian Meal

Conditions studied

Type2diabetes — all drugs for Type2diabetes →
Obesity — all drugs for Obesity →
Diet, Healthy — all drugs for Diet, Healthy →
Nutrition, Healthy — all drugs for Nutrition, Healthy →

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

Adults 18 to 70, any sex, with Type2diabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The role of diet in determining glucose intolerance and its progression towards T2DM has been extensively investigated. A 2017 meta-analysis showed that a vegetarian diet is inversely associated with the risk of developing diabetes. Vegetarians, with the same baseline risk, are half as likely to develop T2DM than those following an omnivorous diet. Therefore, vegetarian nutrition could have important clinical implications in the dietary management of diabetic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type2diabetes

Currently open trials in the same condition.

NCT06345196 — Motivational Interviewing Applied to Individuals With Diabetes · NA · recruiting
NCT06322212 — Type 2 Diabetes and Blood Brain Barrier Improvement · EARLY_PHASE1 · recruiting
NCT06575478 — Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients · Phase 2 · recruiting
NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
NCT06875193 — DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes · Phase 4 · recruiting

Other IRCCS San Raffaele trials

Trials by the same sponsor.

NCT07454759 — Acute Sarcopenia in Hospitalized Older Adults · not yet recruiting
NCT07456462 — Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance · NA · not yet recruiting
NCT07066878 — This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life B · not yet recruiting
NCT07526298 — Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Ap · not yet recruiting
NCT07426471 — Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections. · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06152536 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele
Last refreshed: 30 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06152536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing